Literature DB >> 21351522

[Evaluation of Chinese traditional patent medicines against influenza virus in vitro].

Mian Zu1, Dan Zhou, Li Gao, Ai-lin Liu, Guan-hua Du.   

Abstract

To study in vitro anti-influenza viral activities of Chinese traditional patent medicines for influenza prevention and treatment, neuraminidase (NA) activity assay was used to examine NA inhibitory activity of 33 Chinese traditional patent medicines through fluorimetric assay, and influenza virus induced cytopathic effect (CPE) inhibition assay was used to verify their anti-influenza viral activities in vitro. The assay results showed that most liquid preparations displayed relatively high NA inhibitory activities, such as Shuanghuanglian oral liquid, Qingkailing oral liquid, Qingre Jiedu oral liquid, and Reduning injection. Among liquid preparations, Shuanghuanglian oral liquid not only displayed the highest NA inhibitory effect, but also exhibited obvious in vitro anti-viral activity in CPE experiment. Among solid preparations, Shuanghuanglian powder for injection showed the highest activity on NA inhibition, and Fufang Yuxingcao tablet showed relatively strong anti-influenza viral activity in CPE cells. From the results, it can be concluded that most Chinese traditional patent medicines possessed NA inhibitory activity, but only a few of them displayed significant in vitro anti-influenza viral activities. These results will provide important information for the isolation of active constituents, and for the clinical uses of Chinese traditional patent medicines for influenza treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21351522

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  7 in total

1.  Qingkailing Injection () for Treatment of Children Pneumonia Induced by Respiratory Syncytial Virus: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shuai He; Wen-Shi Li; Ya-Jun Luo; Chen-Li Ye; Zhong-Yi Zhang
Journal:  Chin J Integr Med       Date:  2017-08-17       Impact factor: 1.978

Review 2.  Which East Asian herbal medicines can decrease viral infections?

Authors:  Kenny Kuchta; Silke Cameron; Minwon Lee; Shao-Qing Cai; Yukihiro Shoyama
Journal:  Phytochem Rev       Date:  2021-08-27       Impact factor: 7.741

3.  Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial.

Authors:  Xiu-Hui Li; Shuang-Jie Li; Yi Xu; Dan Wei; Qing-Sheng Shi; Qing-Xiong Zhu; Tong Yang; Jian-Bo Ding; Yi-Mei Tian; Ji-Han Huang; Kun Wang; Tao Wen; Xi Zhang
Journal:  Chin J Integr Med       Date:  2016-07-09       Impact factor: 2.626

4.  Multiscale Modeling of Drug-induced Effects of ReDuNing Injection on Human Disease: From Drug Molecules to Clinical Symptoms of Disease.

Authors:  Fang Luo; Jiangyong Gu; Xinzhuang Zhang; Lirong Chen; Liang Cao; Na Li; Zhenzhong Wang; Wei Xiao; Xiaojie Xu
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

5.  Comparison between Chinese Herbal Medicines and Conventional Therapy in the Treatment of Severe Hand, Foot, and Mouth Disease: A Randomized Controlled Trial.

Authors:  Xiuhui Li; Xi Zhang; Jianbo Ding; Yi Xu; Dan Wei; Yimei Tian; Wei Chen; Jihan Huang; Tao Wen; Shuangjie Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-27       Impact factor: 2.629

6.  Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?

Authors:  Zhenjie Zhuang; Junmao Wen; Lu Zhang; Mingjia Zhang; Xiaoying Zhong; Huiqi Chen; Chuanjin Luo
Journal:  Eur J Integr Med       Date:  2020-05-26       Impact factor: 1.314

7.  Study on the Rationality for Antiviral Activity of Flos Lonicerae Japonicae-Fructus Forsythiae Herb Chito-Oligosaccharide via Integral Pharmacokinetics.

Authors:  Wei Zhou; Ailing Yin; Jinjun Shan; Shouchuan Wang; Baochang Cai; Liuqing Di
Journal:  Molecules       Date:  2017-04-20       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.